2021
Survival of Patients With Mild Secondary Mitral Regurgitation With and Without Mild Tricuspid Regurgitation
Mori M, Weininger G, Agarwal R, Shang M, Amabile A, Kahler-Quesada A, Yousef S, Pichert M, Vallabhajosyula P, Zhang Y, Sugeng L, Geirsson A. Survival of Patients With Mild Secondary Mitral Regurgitation With and Without Mild Tricuspid Regurgitation. Canadian Journal Of Cardiology 2021, 37: 1513-1521. PMID: 34119634, DOI: 10.1016/j.cjca.2021.06.005.Peer-Reviewed Original ResearchConceptsMild secondary mitral regurgitationLeft ventricular ejection fractionSecondary mitral regurgitationMild tricuspid regurgitationNormal left ventricular ejection fractionTricuspid regurgitationHazard of deathGroup 1Valvular abnormalitiesMitral regurgitationGroup 2Mean age 61 yearsGroup 4Cox proportional hazards modelGroup 1 patientsGroup 2 patientsGroup 3 patientsGroup 4 patientsAge 61 yearsRetrospective cohort studySurvival of patientsSubgroup of patientsProportional hazards modelCohort studyHealth care network
2020
United States national trends in comorbidity and outcomes of adult cardiac surgery patients
Mullan CW, Mori M, Pichert MD, Bin Mahmood SU, Yousef S, Geirsson A. United States national trends in comorbidity and outcomes of adult cardiac surgery patients. Journal Of Cardiac Surgery 2020, 35: 2248-2253. PMID: 33448476, DOI: 10.1111/jocs.14764.Peer-Reviewed Original ResearchConceptsMitral valve repair/replacementAortic valve replacementCardiac surgery patientsHospital mortalityLength of staySurgery patientsCardiac surgeryAdult cardiac surgery patientsAdult cardiac surgery proceduresUnited States national trendsValve repair/replacementICD-9 procedure codesCoronary artery bypassCardiac surgery proceduresType of surgeryNational Inpatient SampleICD-9 codesNational trendsCross-sectional analysisCABG/Comorbidity trendsArtery bypassPatient ageValve replacementComorbidity profilesModern Treatment Trends and Outcomes of Pulmonary Embolism With and Without Hemodynamic Significance
Mullan CW, Newman J, Geib M, Pichert MD, Saffarzadeh A, Hartman A, Lima B. Modern Treatment Trends and Outcomes of Pulmonary Embolism With and Without Hemodynamic Significance. The Annals Of Thoracic Surgery 2020, 110: 1534-1540. PMID: 32224241, DOI: 10.1016/j.athoracsur.2020.02.041.Peer-Reviewed Original ResearchConceptsCatheter-directed therapyPulmonary embolismSaddle embolismHospital deathSurgical embolectomySystemic thrombolyticsMembrane oxygenationSaddle pulmonary embolismExtracorporeal membrane oxygenationNational Inpatient SampleNational trendsSystemic thrombolysisPulmonary embolectomyRevision codesInpatient SampleHemodynamic significanceEmbolectomyTreatment trendsEmbolismInternational ClassificationLogistic regressionPopulation-level outcomesTherapyDeathThrombolytics
2019
Elevated risk of death persists beyond 30 days after mitral valve surgery
Mori M, Yousef S, Pichert M, Vinholo TF, Geirsson A. Elevated risk of death persists beyond 30 days after mitral valve surgery. Journal Of Thoracic And Cardiovascular Surgery 2019, 159: e171-e173. PMID: 31420133, DOI: 10.1016/j.jtcvs.2019.07.021.Peer-Reviewed Original Research